✦ LIBER ✦

Lopinavir/Ritonavir Combined with Raltegravir or Tenofovir/Emtricitabine in Antiretroviral-Naive Subjects: 96-Week Results of the PROGRESS Study

✍ Scribed by Reynes, Jacques; Trinh, Roger; Pulido, Federico; Soto-Malave, Ruth; Gathe, Joseph; Qaqish, Roula; Tian, Min; Fredrick, Linda; Podsadecki, Thomas; Norton, Michael; Nilius, Angela

Book ID: 118117005
Publisher: Mary Ann Liebert
Year: 2013
Tongue: English
Weight: 363 KB
Volume: 29
Category: Article
ISSN: 0889-2229
DOI: 10.1089/aid.2011.0275

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ritonavir-boosted darunavir combined wit

Ritonavir-boosted darunavir combined with raltegravir or tenofovir–emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial

✍ Raffi, François; Babiker, Abdel G; Richert, Laura; Molina, Jean-Michel; George, 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 395 KB

Once-daily atazanavir/ritonavir versus t

Once-daily atazanavir/ritonavir versus twice-daily lopinavir/ritonavir, each in combination with tenofovir and emtricitabine, for management of antiretroviral-naive HIV-1-infected patients: 48 week efficacy and safety results of the CASTLE study

✍ Jean-Michel Molina; Jaime Andrade-Villanueva; Juan Echevarria; Ploenchan Chetcho 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 246 KB

Long-term (96-week) follow-up of antiret

Long-term (96-week) follow-up of antiretroviral-naïve HIV-infected patients treated with first-line lopinavir/ritonavir monotherapy in the MONARK trial

✍ J Ghosn; P Flandre; I Cohen-Codar; P-M Girard; M-L Chaix; F Raffi; P Dellamonica 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB